KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Buildings (2016 - 2025)

Gilead Sciences (GILD) has disclosed Buildings for 16 consecutive years, with $4.6 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Buildings rose 1.83% year-over-year to $4.6 billion, compared with a TTM value of $4.6 billion through Dec 2025, up 1.83%, and an annual FY2025 reading of $4.6 billion, up 1.83% over the prior year.
  • Buildings was $4.6 billion for Q4 2025 at Gilead Sciences, up from $4.5 billion in the prior quarter.
  • Across five years, Buildings topped out at $4.6 billion in Q4 2025 and bottomed at $3.8 billion in Q4 2021.
  • Average Buildings over 5 years is $4.3 billion, with a median of $4.4 billion recorded in 2022.
  • The sharpest move saw Buildings rose 15.71% in 2022, then fell 1.41% in 2023.
  • Year by year, Buildings stood at $3.8 billion in 2021, then increased by 15.71% to $4.4 billion in 2022, then fell by 1.41% to $4.3 billion in 2023, then rose by 4.88% to $4.5 billion in 2024, then rose by 1.83% to $4.6 billion in 2025.
  • Business Quant data shows Buildings for GILD at $4.6 billion in Q4 2025, $4.5 billion in Q4 2024, and $4.3 billion in Q4 2023.